NVE's Blowout Quarter and the Wager on a New Growth Plateau

NVE Corporation posted a blockbuster fiscal first-quarter (June 2026) with revenue jumping 81% year-over-year to $11.0 million, net income up 79% to $6.39 million, and diluted EPS of $1.32. The stock has risen 43% over the last three months to a peak of $134.21 on July 23, then retreated 18% as the market weighs whether this is a new plateau or another intermittent spike. The quarter also coincides with a planned leadership transition.

The Blowout Quarter

The revenue surge is a stark departure from a decade of flat growth. CEO Dan Baker opened the call: “Our growth accelerated with an 81% increase in revenue and a 79% increase in net income, driven by new product sales and a strong semiconductor market.” — Daniel Baker, President and CEO · 2026-07-22 CFO Daniel Nelson detailed the margins: “Operating margin was 66%, Pretax margin was 78% and net margin was 58%.” — Daniel Nelson, Principal Financial Officer · 2026-07-22 Gross margin expanded to 81.3% from 78.6% a year ago on higher volumes. This performance comes after years of quarterly revenue oscillating between $5 million and $8 million. The company's total revenue grew only 9% cumulatively over the past decade, making this quarter's $11 million print a step-change in scale. Management attributes the acceleration to new products and a recovering semiconductor industry, echoing the optimism expressed on prior calls when CFO Daniel Nelson noted, “We are starting to see the results of our R&D and our expansion plans already.” — Daniel Baker, President and CEO · 2025-10-22

New Product Cycle: Medical, Robotics, and Power

At the heart of the growth is a new product cycle. VP of Advanced Technology Pete Eames announced the launch of two wafer-level chip-scale sensors for implantable medical devices: “The new parts are about 1/3 of the area of the conventionally packaged versions... The sensor functions as a magnetic switch in a normal magnetic field and the sensors are stable to very high magnetic fields of over 9 Tesla, which is more than the fields produced by the strongest MRI machines.” — Peter Eames, Vice President of Advanced Technology and CEO (incoming) · 2026-07-22 This addresses a critical patient safety issue—many implantable devices are not MRI-compatible. The sensor leverages the company's proprietary magnetic switch technology and builds on years of sampling wafer-level chip-scale parts. When asked about the strongest end market, Eames identified robotics: “We'd say that's probably the strongest growing area and the most promising for our technology.” — Peter Eames, Vice President of Advanced Technology and CEO (incoming) · 2026-07-22 The company is also positioned for data centers through its high-isolation power conversion isolators, a segment it has targeted for several quarters. In January, Eames had telegraphed the strategy: “We have been sampling the products for several quarters now. We have customer interest, and we're continuing to expand that product line. So we expect it to be a significant growth driver going forward.” — Daniel Baker, President and CEO · 2025-10-22 That expectation is now beginning to materialize.

Leadership and Strategic Transition

The quarter also marks a governance inflection. Dan Baker announced his retirement as President and CEO effective at the annual meeting, with Pete Eames, the head of advanced technology, named as his successor. The board will expand from five to seven directors, adding Carolyn Valentine. Baker closed the call with a note of confidence:

We were pleased to report a blowout quarter with an 81% increase in revenue, a 79% increase in net income and $1.32 earnings per share.